Parabilis Medicines is taking an early lead in the 2026 biotech fundraising race, closing a $305 million series F round that ...

Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...

This article originally appeared on Inside Climate News, a nonprofit, non-partisan news organization that covers climate, ...

As 2026 approached the Prince and Princess of Wales posted a social media carousel of a dozen never-before-seen photographs from the year gone by.A reflective close-up of lighting candles on Holocaust ...

Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

The Princess of Wales made an unannounced visit to London's Charing Cross hospital today, where she spoke candidly about her ...

From encouraging ideas about climate solutions to dystopian views of the future, climate leaders found a lot to read over the ...

King Charles reportedly told Harry he was "not a bank" after the Duke of Sussex "demanded funds." Learn more, here.

Here are reviews of five of the best available books on blockchain, a relatively new, but rapidly growing and very important ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Tumor immunotherapy has rapidly emerged as a cornerstone in oncology, revolutionizing the treatment landscape for patients with advanced malignancies.